Search research articles
Contact Us
Filters
Showing results (101-110 of 115) with videos related to
Page
of 12
Sort By:
Public Health
|
July 9, 2022
An evaluation of a pilot of daily testing of SARS-CoV-2 contacts in acute hospital and ambulance trusts in England
S M A Bow, A Goddard, G Cope, et al.
Journal of Cellular Physiology
|
November 21, 2009
Zyxin controls migration in epithelial-mesenchymal transition by mediating actin-membrane linkages at cell-cell junctions
Rebecca Bakkevig Sperry, Nicholas H Bishop, Jeremy J Bramwell, et al.
The Journal of Clinical Endocrinology and Metabolism
|
November 5, 2023
Efficacy and Safety of Teprotumumab in Patients With Thyroid Eye Disease of Long Duration and Low Disease Activity
Raymond S Douglas, Steven Couch, Sara T Wester, et al.
Epidemiology and Infection
|
October 2, 2015
Association between use of proton pump inhibitors and non-typhoidal salmonellosis identified following investigation into an outbreak of Salmonella Mikawasima in the UK, 2013
R Freeman, G Dabrera, C Lane, et al.
Nucleosides & Nucleotides
|
August 5, 1999
Gene therapy of cancer: activation of nucleoside prodrugs with E. coli purine nucleoside phosphorylase
J A Secrist, W B Parker, P W Allan, et al.
Viruses
|
May 27, 2023
Novel Adjuvant S-540956 Targets Lymph Nodes and Reduces Genital Recurrences and Vaginal Shedding of HSV-2 DNA When Administered with HSV-2 Glycoprotein D as a Therapeutic Vaccine in Guinea Pigs
Sita Awasthi, Motoyasu Onishi, John M Lubinski, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 20, 2011
Novel substituted pyrimidines as HCV replication (replicase) inhibitors
Cecil D Kwong, Jeremy L Clark, Anita T Fowler, et al.
The Journal of Bone and Joint Surgery. American Volume
|
January 7, 2021
Low Adherence to Recommended Guidelines for Open Fracture Antibiotic Prophylaxis
Carol A Lin, Nathan N O'Hara, Sheila Sprague, et al.
Ophthalmology
|
October 24, 2021
Teprotumumab Efficacy, Safety, and Durability in Longer-Duration Thyroid Eye Disease and Re-treatment: OPTIC-X Study
Raymond S Douglas, George J Kahaly, Shoaib Ugradar, et al.
The New England Journal of Medicine
|
January 24, 2020
Teprotumumab for the Treatment of Active Thyroid Eye Disease
Raymond S Douglas, George J Kahaly, Amy Patel, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 115) with videos related to
Sort By:
Page
of 12
Public Health
|
July 9, 2022
An evaluation of a pilot of daily testing of SARS-CoV-2 contacts in acute hospital and ambulance trusts in England
S M A Bow, A Goddard, G Cope, et al.
Journal of Cellular Physiology
|
November 21, 2009
Zyxin controls migration in epithelial-mesenchymal transition by mediating actin-membrane linkages at cell-cell junctions
Rebecca Bakkevig Sperry, Nicholas H Bishop, Jeremy J Bramwell, et al.
The Journal of Clinical Endocrinology and Metabolism
|
November 5, 2023
Efficacy and Safety of Teprotumumab in Patients With Thyroid Eye Disease of Long Duration and Low Disease Activity
Raymond S Douglas, Steven Couch, Sara T Wester, et al.
Epidemiology and Infection
|
October 2, 2015
Association between use of proton pump inhibitors and non-typhoidal salmonellosis identified following investigation into an outbreak of Salmonella Mikawasima in the UK, 2013
R Freeman, G Dabrera, C Lane, et al.
Nucleosides & Nucleotides
|
August 5, 1999
Gene therapy of cancer: activation of nucleoside prodrugs with E. coli purine nucleoside phosphorylase
J A Secrist, W B Parker, P W Allan, et al.
Viruses
|
May 27, 2023
Novel Adjuvant S-540956 Targets Lymph Nodes and Reduces Genital Recurrences and Vaginal Shedding of HSV-2 DNA When Administered with HSV-2 Glycoprotein D as a Therapeutic Vaccine in Guinea Pigs
Sita Awasthi, Motoyasu Onishi, John M Lubinski, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 20, 2011
Novel substituted pyrimidines as HCV replication (replicase) inhibitors
Cecil D Kwong, Jeremy L Clark, Anita T Fowler, et al.
The Journal of Bone and Joint Surgery. American Volume
|
January 7, 2021
Low Adherence to Recommended Guidelines for Open Fracture Antibiotic Prophylaxis
Carol A Lin, Nathan N O'Hara, Sheila Sprague, et al.
Ophthalmology
|
October 24, 2021
Teprotumumab Efficacy, Safety, and Durability in Longer-Duration Thyroid Eye Disease and Re-treatment: OPTIC-X Study
Raymond S Douglas, George J Kahaly, Shoaib Ugradar, et al.
The New England Journal of Medicine
|
January 24, 2020
Teprotumumab for the Treatment of Active Thyroid Eye Disease
Raymond S Douglas, George J Kahaly, Amy Patel, et al.
Page
of 12